Hira Verma
Hira VermaChairman and CEO

Hira has over 20 years of business experience in the corporate world spanning the biotech, consumer, industrial, education and technology sectors. He is currently Co-Founder & CEO of Haplo Therapeutics, a biotech company advancing small molecule therapeutics principally for rare neurodevelopmental and common neurodegenerative diseases.  Hira was previously a Director within Scotiabank’s Investment Banking Division in Toronto, as well as a Vice President at Deutsche Bank in New York.  Through his time at Scotiabank and Deutsche Bank, Hira advised on over $14 billion of transactions involving mergers, acquisitions and financings.  Prior to his career in finance, Hira held progressively senior roles in brand and product management working for Procter & Gamble and Nestle.

Beyond work, Hira is passionate about film with a particular interest in documentaries that advocate positive social change. Hira graduated with a Master of Business Administration from the Harvard Business School and Bachelor of Business Administration from York University’s Schulich School of Business in Toronto.